All SCARB2 reagents are produced in house and quality controlled, including 7 SCARB2 Antibody, 36 SCARB2 Gene, 2 SCARB2 Lysate, 2 SCARB2 Protein, 2 SCARB2 qPCR. All SCARB2 reagents are ready to use.
Recombinant SCARB2 proteins are expressed by HEK293 Cells with fusion tags as C-human IgG1-Fc & His, C-His.
SCARB2antibodies are validated with different applications, which are IHC-P, FCM, ICC/IF, IF, ELISA.
SCARB2cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each SCARB2 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.
Lysosomal Integral Membrane Protein II (LIMPII), also known as SCARB2, LPG85, and CD36L2, is a type I II multi-pass membrane glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes on all tissues and cell types so far examined. This protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. LIMPII is identified as a receptor for EV71 (human enterovirus species A, Enterovirus 71) and CVA16 (coxsackievirus A16) which are most frequently associated with hand, foot and mouth disease (HFMD). Expression of human LIMPII enables normally unsusceptible cell lines to support the viruses’ propagation and develop cytopathic effects. In addition, LIMPII also has been shown to bind thrombospondin-1, may contribute to the pro-adhesive changes of activated platelets during coagulation, and inflammation. Deficiency of the protein in mice impairs cell membrane transport processes and causes pelvic junction obstruction, deafness, and peripheral neuropathy.